Matchpoint Therapeutics Funding: $100M Raised, Series A
Matchpoint Therapeutics is a Biotech company based in Cambridge. It has raised $100M in total funding. Latest round: Series A.
Matchpoint Therapeutics funding overview
Matchpoint Therapeutics is a Biotech company based in Cambridge. Matchpoint Therapeutics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in October 2022. The round record for Matchpoint Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Sanofi Ventures, Atlas Venture, Access Biotechnology, Vertex Ventures HC, Digitalis Ventures, Alexandria Venture Investments. 6 distinct backers are named across the disclosed rounds.
Frequently asked about Matchpoint Therapeutics funding
How much has Matchpoint Therapeutics raised?
Matchpoint Therapeutics has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Matchpoint Therapeutics?
Sanofi Ventures, Atlas Venture, Access Biotechnology, Vertex Ventures HC, Digitalis Ventures, Alexandria Venture Investments are named among the investors backing Matchpoint Therapeutics.
What was the latest Matchpoint Therapeutics funding round?
The most recent disclosed round is a Series A, announced in October 2022.
Where is Matchpoint Therapeutics based?
Matchpoint Therapeutics is based in Cambridge.
What sector does Matchpoint Therapeutics operate in?
Matchpoint Therapeutics is tracked under Biotech from Cambridge, with $100M in disclosed funding.
When did Matchpoint Therapeutics last raise?
The last disclosed Matchpoint Therapeutics round closed in October 2022 at Series A.
Round data for Matchpoint Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Cambridge and backer lists below.
